Schwab Andrew J. sold SKYE
September 22, 2026 · Form 4 insider transaction
Schwab Andrew J. sold 27,612 shares of Skye Bioscience, Inc. at $1.65 per share, a transaction worth $45.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
27,612
Price
$1.65
Total value
$45.6K
InsiderSchwab Andrew J.
RoleDirector, 10% owner
CompanySkye Bioscience, Inc. (SKYE)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 22, 2026
Filing dateSeptember 24, 2026
Shares owned after114,851
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are directly held by 5AM Ventures II, L.P. ("Ventures II"). 5AM Partners II, LLC ("Partners II") is the sole general partner of Ventures II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.